Edition:
United States

ResMed Inc (RMD.N)

RMD.N on New York Stock Exchange

72.38USD
22 Feb 2017
Change (% chg)

$0.17 (+0.24%)
Prev Close
$72.21
Open
$72.29
Day's High
$72.69
Day's Low
$71.92
Volume
323,707
Avg. Vol
275,449
52-wk High
$72.69
52-wk Low
$55.15

RMD.N

Chart for RMD.N

About

ResMed Inc. is a holding company. The Company is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease (COPD),... (more)

Overall

Beta: 0.86
Market Cap(Mil.): $10,229.05
Shares Outstanding(Mil.): 141.66
Dividend: 0.33
Yield (%): 1.83

Financials

  RMD.N Industry Sector
P/E (TTM): 30.62 52.89 29.35
EPS (TTM): 2.36 -- --
ROI: 14.49 7.57 12.97
ROE: 20.67 11.40 14.11

BRIEF-ResMed reports Q2 earnings per share $0.54

* Announces results for the second quarter of fiscal year 2017

Jan 23 2017

BRIEF-Resmed and BMC/3B Medical settle global litigation

* Resmed Inc - Settlement did not include an admission of liability or wrongdoing by any party

Jan 20 2017

BRIEF-FDA clears world's smallest CPAP, ResMed AirMini

* FDA clears world's smallest CPAP, ResMed AirMini Source text for Eikon: Further company coverage:

Jan 09 2017

Fisher & Paykel wins German court case against ResMed

WELLINGTON Fisher & Paykel Healthcare Corporation Ltd said on Friday a German court has overturned both preliminary injunctions granted to ResMed Inc, which had taken legal action against the New Zealand-based medical device maker.

Dec 01 2016

BRIEF-ResMed announces results for Q1 of fiscal year 2017

* ResMed Inc. announces results for the first quarter of fiscal year 2017

Oct 25 2016

More From Around the Web

Earnings vs. Estimates